Showing results (171-180 of 218) with videos related to

Sort By:
Pageof 22
Nature Communications|January 18, 2022
Epigenetic aging of the demographically non-aging naked mole-ratCsaba Kerepesi, Margarita V Meer, Julia Ablaeva, et al.
The Journal of Investigative Dermatology|June 12, 2022
Skin Aging in Long-Lived Naked Mole-Rats Is Accompanied by Increased Expression of Longevity-Associated and Tumor Suppressor GenesIqra Fatima, Guodong Chen, Natalia V Botchkareva, et al.
Science Advances|June 7, 2024
Epigenetic predictors of species maximum life span and other life-history traits in mammalsCaesar Z Li, Amin Haghani, Qi Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung CancerSuresh S Ramalingam, Normand Blais, Julien Mazieres, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Neuropeptides specify and reprogram division of labor in the leafcutter ant Atta cephalotesMichael B Gilbert, Karl M Glastad, Maxxum Fioriti, et al.
Scientific Reports|January 28, 2017
Lipidome determinants of maximal lifespan in mammalsKatarzyna Bozek, Ekaterina E Khrameeva, Jane Reznick, et al.
Neuroendocrinology|September 25, 2018
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) NeoplasmsEric Baudin, Aimee R Hayes, Jean-Yves Scoazec, et al.
Scientific Reports|May 3, 2019
Publisher Correction: Lipidome determinants of maximal lifespan in mammalsKatarzyna Bozek, Ekaterina E Khrameeva, Jane Reznick, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 5, 2020
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGSJosep Tabernero, Maria Alsina, Kohei Shitara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancerJohn R Mackey, Manuel Ramos-Vazquez, Oleg Lipatov, et al.
Pageof 22